The 1 year outcome of intravitreal dexamethasone implant for macular edema secondary to central retinal vein occlusion

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|94|S256|j.1755-3768.2016.0263-j.1755-3768.2016.0263

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.94, Iss.S256, 2016-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti-Vascular Endothelial Growth Factors

By  

Current Drug Safety, Vol. 10, Iss. 2, 2015-07 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

Injections in retinal vein occlusions

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 650-655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion‐related macular oedema: a prospective randomized comparison – response

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 5, 2015-07 ,pp. : 497-498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion‐related macular oedema: a prospective randomized comparison – comment

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 5, 2015-07 ,pp. : 497-497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 431-434

John Wiley & Sons Inc

Access to resources Recommend Favorite